Glacier Peak Capital’s Biogen BIIB Stock Holding History

Glacier Peak Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$216K	Sell	928 -11,836	-93%	-$2.76M	0.22%	63
2019 Q2	$2.98M	Buy	+12,764	New	+$2.95M	2.83%	8
2016 Q3	–	Sell	-24,284	Closed	-$5.87M	–	30
2016 Q2	$5.87M	Hold	24,284	–	–	6.22%	5
2016 Q1	$6.32M	Hold	24,284	–	–	5.43%	5
2015 Q4	$186K	Buy	24,284 +284	+1%	+$81.6K	0.12%	63
2015 Q3	$7M	Sell	24,000 -500	-2%	-$165K	3.88%	5
2015 Q2	$9.9M	Buy	24,500 +500	+2%	+$201K	4.99%	3
2015 Q1	$10.1M	Hold	24,000	–	–	4.94%	4
2014 Q4	$8.15M	Buy	24,000 +9,000	+60%	+$2.91M	4.13%	5
2014 Q3	$4.96M	Buy	15,000 +3,000	+25%	+$989K	2.74%	8
2014 Q2	$3.78M	Buy	+12,000	New	+$3.61M	2.36%	11

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Glacier Peak Capital's BIIB Position: Q3 2019 in Review

Glacier Peak Capital reduced its Biogen (BIIB) stake by 93% in Q3 2019, selling an estimated $2.76M and leaving 928 shares worth $216K. The position accounts for 0.22% of the portfolio, ranked #63.

Glacier Peak Capital first reported a position in BIIB in Q2 2014 and has held it in 11 quarters since. The position peaked at $10.1M in Q1 2015. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Glacier Peak Capital held 928 shares of Biogen worth $216K as of Q3 2019.
Glacier Peak Capital sold 11,836 Biogen shares in Q3 2019, an estimated $2.76M.
Biogen made up 0.22% of Glacier Peak Capital's portfolio in Q3 2019, its #63 holding.
Glacier Peak Capital first reported a position in Biogen in Q2 2014 and has held it in 11 quarters since.
Glacier Peak Capital's Biogen position peaked at $10.1M in Q1 2015.
989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Glacier Peak Capital's 13F filing for Q3 2019, filed 12 Nov 2019.